Overview
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com
Job Function: Medical Affairs Group
Job Sub Function: Medical Affairs
Job Category: People Leader
All Job Posting Locations: High Wycombe, Buckinghamshire, United Kingdom
Job Description: Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine
We are looking for an EMEA Medical Affairs Director, Evidence Strategy, to be based in EMEA. The EMEA Medical Affairs Director, Evidence Strategy is responsible for evolving and leading our EMEA strategic evidence generation process across the lifecycle in the Janssen pipeline. The ability of J&J EMEA to achieve rapid, optimal market access and differentiation versus competitor medicines is influenced by evidence generation decisions anticipated early in the product lifecycle extending beyond launch into the mature life cycle. This role reports directly to the ESO Medical Excellence Senior Director, EMEA Operational Excellence Strategy. The objective of this role is to oversee (input into redesign and coordinate implementation of) a best in class end-to-end evidence generation strategy for EMEA on the Medical but also Access aspects.
Key Responsibilities
Oversee best in class EMEA cross-TA evidence generation strategy:
* Establish a clear cross-TA process and operating model for:
* Evidence Generation short to long term plans
* EMEA Integrated Evidence Generation and Dissemination Plan
* Lead regional IEGP process for EMEA region:
* train IBVT and CVT teams on their responsibilities and key deliverables
* organize and chair IEGP strategy (Q1) and IEGP tactics (Q2) review
* establish a prioritization for ESO EG investments
* present consolidated plans and seek endorsement from relevant leadership bodies (ESLT, ELT)
* Coordinate EMEA contribution to WW IEGP process
* align deliverables of EMEA and WW IEGP process
* review and provide recommendation to optimize impact of WW IEGP for EMEA
* Work with VP MAF and VP HEMAR to agree and finalize the above.
* Oversee communication (regionally, locally and globally) and roll out of EMEA plans involving key stakeholders.
* Identify and collate with key stakeholders (ETAHs, TAMALs, GMALs, Opco TA teams) a core set of evidence deliverables and associated timelines that will create value for EMEA
* Incorporate competitive insights cross-TA via new CI tools (Insight Miner) in conjunction with CDS
* Design and track medical and business impact of EMEA IEGP
* Establish collaboration model with EMEA HEMAR team and MAF TA teams and establish a clear set of roles and responsibilities
* Strengthen engagement and processes with key countries to ensure their input
* Identify critical priorities for key countries across EMEA and facilitate early engagement and dialogue between major EMEA markets and global decision-makers
* Identify opportunities to strengthen EMEA input into core company processes, such as early CDP shaping, TPP development, regulatory filing discussions
* Continually assess the need for new organisational capabilities or resources to effectively support cross-TA evidence strategy development
* Input as needed into company processes such as long-range financial planning
Essential Knowledge & Skills:
* The successful candidate requires extensive Pharmaceutical background and will have demonstrated a Regional mind-set with the ability to assimilate complex science and data quickly. A higher scientific degree is desired e.g. PhD or MD.
* Must exhibit behaviours aligned to the J&J Global Leadership Profile including but not limited to: integrity-credo based actions, collaboration and teamwork, sense of urgency, results driven and people development.
* This position requires up to 10% travel.
* Fluency in English language required
* Fluency in additional EMEA languages an advantage
Experience
* A minimum of 8 years of progressive Medical Affairs experience is required with a proven track record of exceptional team & cross-functional leadership.
* Experience with R&D programs and the development of commercial and evidence generation strategy is required.
* > 5 years being part of teams generating Evidence Generation plans
* > 5 years being part of teams planning and executing Medical Education plans
The role is EMEA based and is likely to involve extensive EMEA and International travel. The role holder will be expected to be based in their current country of residence as long as easy access to travel/ transportation and local hosting is available in a JJIM office.
Please note that this role is available across multiple countries and may be posted under different requisition numbers to comply with local requirements. While you are welcome to apply to any or all of the postings, we recommend focusing on the specific country(s) that align with your preferred location(s):
UK: R-032723
Switzerland: R-032718
All other EMEA locations: R-032431
#J-18808-Ljbffr